Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $137.7300 (-0.33%) ($136.9050 - $139.6700) on Mon. Jun. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.46% (three month average) | RSI | 33 | Latest Price | $137.7300(-0.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.1% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(12%) TAN(12%) XBI(12%) ICLN(11%) PCY(11%) | Factors Impacting ABBV price | ABBV will decline at least -0.73% in a week (0% probabilities). BWX(-13%) BNDX(-13%) XLI(-10%) XLC(-10%) IYT(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.73% (StdDev 1.46%) | Hourly BBV | -0.3 () | Intraday Trend | -1.3% | | | |
|
Resistance Level | $139.49 | 5 Day Moving Average | $137.1(0.46%) | 10 Day Moving Average | $136.74(0.72%) | 20 Day Moving Average | $139.49(-1.26%) | To recent high | -16.5% | To recent low | 3.2% | Market Cap | $242.995b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |